Global Glaucoma Market, By Type (Closed Angle Glaucoma (CAG), Open Angle Glaucoma (OAG), Secondary Glaucoma, Congenital Glaucoma, Others), Drug Class (Beta Blockers, Prostaglandins, Alpha Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Combination Drugs, Others), Route of Administration (Oral, Injections, Intravitreal, Others), End-Users (Hospitals, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights : Global Glaucoma Market
The glaucoma market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with the CAGR of 7.05% in the forecast period of 2021 to 2028. The increasing prevalence of glaucoma diseases will help in escalating the growth of the glaucoma market.
The Glaucoma is one of the major eyes disorders which results in the damage to the optic nerve. Glaucoma can result in vision loss and blindness. There are several drugs utilized for the diagnosis of this disease. Some of them are Beta blocker, Alpha-adrenergic agonists, Hyperosmotics, and Carbonic anhydrase inhibitors.
Factors such as quick speed because of the some of the main factors for example the increasing prevalence of glaucoma diseases around of the world, growing of the old age population in several countries has become one of the factors that will boost the growth of the glaucoma market in the forecast period. Several initiatives by the administration and healthcare organisations in order to cure glaucoma regarding the difficulties and suitable repayment rules regarding to glaucoma treatment are anticipated to propel the growth in the glaucoma market in the forecast period.
Additionally, continuous inventions in the drugs and the increasing number of patients with diabetes are to extend profitable opportunities for the growth of the glaucoma market in the coming years. However, the lack of alertness about the disease and its treatment in several rising and underdeveloped countries, and postoperative problems resulting after glaucoma surgery further challenge the growth of the glaucoma market in the coming years.
This glaucoma market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on glaucoma market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Glaucoma Market Scope and Market Size
The glaucoma market is segmented on the basis of type, drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on the type, the glaucoma market is segmented into closed angle glaucoma (CAG), open angle glaucoma (OAG), secondary glaucoma, congenital glaucoma, others.
- Based on the drug class, the glaucoma market is segmented into beta blockers, prostaglandins, alpha adrenergic agonist, carbonic anhydrase inhibitors, combination drugs, others.
- Based on the route of administration, the glaucoma market is segmented into oral, injections, intravitreal, others.
- Based on the end-users, the glaucoma market is segmented into hospitals, speciality centres, others.
- Based on distribution channel, the glaucoma market is segmented into hospital pharmacy, online pharmacy, retail pharmacy.
Glaucoma Market Country Level Analysis
The glaucoma market is analysed and market size insights and trends are provided by country, type, drug class, route of administration, end-users and distribution channel as referenced above.
The countries covered in the glaucoma market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the glaucoma market because of the high incidences of glaucoma, and the economic stability which outcomes to high healthcare spending. Furthermore, huge population suffering from diabetes and other eye diseases. Additionally, the improved infrastructure which in turn will expected to boost the growth of the glaucoma market in the region during the forecast period. Europe is projected to observe significant amount of growth in the glaucoma market because of the ability of strong repayment rules and high occurrence of patient’s pool.
The country section of the glaucoma market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The glaucoma market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for glaucoma market, impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the glaucoma market. The data is available for historic period 2010-2019.
Competitive Landscape and Glaucoma Market Share Analysis
The glaucoma market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to glaucoma market.
The major players covered in the glaucoma market report are Aerie Pharmaceuticals, Inc., Allergan, Bausch Health, Merck & Co. Inc., Pfizer Inc., Fera Pharmaceuticals, Teva Pharmaceutical Industries Ltd., EyePoint Pharmaceuticals, Amorphex Therapeutics LLC., ellex, Quantel, Lumenis, Acorn Biomedical, Inc, Acucela Inc., Alcon, Astellas Pharma Inc., Bayer AG, BioAxone, and Novartis AG, Carl Zeiss Meditec, Alcon, Lumenis, Topcon Medical Systems, Nidek, OPHTEC, Accutome, AqueSys, Canon, Essilor, Iridex Corporation, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-